Immuneering (IMRX) Change in Account Payables (2020 - 2024)
Historic Change in Account Payables for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to $56741.0.
- Immuneering's Change in Account Payables fell 6673.41% to $56741.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$112143.0, marking a year-over-year increase of 8986.87%. This contributed to the annual value of -$112143.0 for FY2024, which is 8986.87% up from last year.
- According to the latest figures from Q4 2024, Immuneering's Change in Account Payables is $56741.0, which was down 6673.41% from -$679454.0 recorded in Q3 2024.
- Immuneering's 5-year Change in Account Payables high stood at $1.1 million for Q3 2022, and its period low was -$778202.0 during Q3 2023.
- Its 5-year average for Change in Account Payables is $55249.7, with a median of $90557.0 in 2021.
- As far as peak fluctuations go, Immuneering's Change in Account Payables plummeted by 73106.51% in 2022, and later surged by 67541.75% in 2024.
- Quarter analysis of 5 years shows Immuneering's Change in Account Payables stood at $274072.0 in 2020, then tumbled by 262.37% to -$445014.0 in 2021, then skyrocketed by 283.4% to $816177.0 in 2022, then plummeted by 79.1% to $170568.0 in 2023, then crashed by 66.73% to $56741.0 in 2024.
- Its Change in Account Payables was $56741.0 in Q4 2024, compared to -$679454.0 in Q3 2024 and $393177.0 in Q2 2024.